Cubist options unusually active before Merck deal
NEW YORK, Dec 8 (Reuters) - Cubist Pharmaceuticals Inc options had one of their most active weeks this year last week ahead of Monday's announcement that Merck & Co will buy Cubist for a hefty...
Read more »